Previous Close | 5.65 |
Open | 5.65 |
Bid | 0.00 x 1300 |
Ask | 0.00 x 3100 |
Day's Range | 5.65 - 6.25 |
52 Week Range | 2.69 - 7.25 |
Volume | |
Avg. Volume | 7,770 |
Market Cap | 47.98M |
Beta (5Y Monthly) | 0.49 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.14 |
Earnings Date | Apr 19, 2024 - Apr 23, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Sep 01, 2022 |
1y Target Est | 8.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for CCEL
OLDSMAR, Fla., February 28, 2024--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2023.
NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the 2024 Healthcare IT Virtual Conference. The conference will take place on Wednesday, January 24th, & Thursday, January 25th, 2024, starting at 9:00 a.m. ET. We will be presenting our 2024 Healthcare IT Virtual Conference. Allen Klee, Senior Research Analyst at Maxim Grou
OLDSMAR, Fla., October 12, 2023--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the "Company"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2023.